Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06300411
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-03-01
Brief Title:
SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
Sponsor:
SURGE Therapeutics
Organization:
SURGE Therapeutics
Organization Data
Organization:
SURGE Therapeutics
Class:
INDUSTRY
Study ID:
SRG-514-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SURGE Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None